These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Treatment of toxoplasmosis (author's transl)]. Apt W Rev Med Chil; 1978 Aug; 106(8):622-5. PubMed ID: 725384 [No Abstract] [Full Text] [Related]
26. Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii. Gross U; Pohl F Curr Top Microbiol Immunol; 1996; 219():235-45. PubMed ID: 8791704 [No Abstract] [Full Text] [Related]
27. [Remarks on toxoplasmosis therapy based on indications]. Baumgarten R Z Arztl Fortbild (Jena); 1985; 79(12):509-10. PubMed ID: 4036178 [No Abstract] [Full Text] [Related]
28. Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity. Neville AJ; Zach SJ; Wang X; Larson JJ; Judge AK; Davis LA; Vennerstrom JL; Davis PH Antimicrob Agents Chemother; 2015 Dec; 59(12):7161-9. PubMed ID: 26392504 [TBL] [Abstract][Full Text] [Related]
29. [New viewpoints on the treatment of toxoplasmosis]. Kocher R; Haensch G Dtsch Med Wochenschr; 1973 Oct; 98(41):1920-3. PubMed ID: 4206221 [No Abstract] [Full Text] [Related]
30. [Justification and methods of preventive treatment in chronic toxoplasmosis during pregnancy (author's transl)]. Vojta M; Avratová L; Balák K; Fuchs V; Pakan J Cesk Gynekol; 1974 Jul; 39(6):433-6. PubMed ID: 4849021 [No Abstract] [Full Text] [Related]
31. Anticoccidial activity of 2-sulfamoyl-4,4-diaminodiphenylsulfone, sulfadiazine, pyrimethamine and clindamycin in cats infected with Toxoplasma gondii. Dubey JP; Yeary RA Can Vet J; 1977 Mar; 18(3):51-7. PubMed ID: 858118 [No Abstract] [Full Text] [Related]
32. [Therapy of toxoplasmosis]. van der Veen J Ned Tijdschr Geneeskd; 1979 Apr; 123(14):564-6. PubMed ID: 431741 [No Abstract] [Full Text] [Related]
34. [New aspects of the treatment of toxoplasmosis (author's transl)]. Lafrenz M; Ziegler K; Sänger R; Budde E; Naumann G Munch Med Wochenschr; 1973 Nov; 115(46):2057-61. PubMed ID: 4801335 [No Abstract] [Full Text] [Related]
35. Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone. Vergani P; Ghidini A; Ceruti P; Strobelt N; Spelta A; Zapparoli B; Rescaldani R Am J Reprod Immunol; 1998 May; 39(5):335-40. PubMed ID: 9602252 [TBL] [Abstract][Full Text] [Related]
36. Role of clindamycin in the treatment of central nervous system toxoplasmosis. Rolston KV; Hoy J Am J Med; 1987 Sep; 83(3):551-4. PubMed ID: 3661590 [TBL] [Abstract][Full Text] [Related]
37. [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin]. Colin J; Harie JC J Fr Ophtalmol; 1989; 12(3):161-5. PubMed ID: 2695556 [TBL] [Abstract][Full Text] [Related]
38. [Toxoplasmosis and pregnancy]. Grio R; Piacentino R; Corbella O; Tagliati D; De Pascale A Minerva Ginecol; 1982 Jun; 34(6):405-12. PubMed ID: 7133525 [No Abstract] [Full Text] [Related]
39. Comparison of adverse reactions of spiramycin versus pyrimethamine/sulfadiazine treatment of toxoplasmosis in pregnancy: is spiramycin really the drug of choice for unproven infection of the fetus? Prasil P; Sleha R; Kacerovsky M; Bostik P J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2215377. PubMed ID: 37217458 [TBL] [Abstract][Full Text] [Related]